44R-27704-67572 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Dose 1 — Moderna
2021-04-10
Dose 2 — Moderna
2021-04-28
Registered in v-safe
2021-04-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-01
Survey response — day 21, dose 2
MedDRA: Amenorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Missed period. Confirmed that I am not pregnant

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Report sent to call center — day 21, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-11
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-04-12
Survey response — 12 months, dose 2
MedDRA: Cutaneous vasculitis — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Leukocytoclastic vasculitis

MedDRA releases: 2024-11 · check-in free text available
2022-04-12
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2022-04-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Moderna
2	2021-04-10	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-05-01	Unsuccessful
2022-04-12	Unsuccessful

Free text

Release 8 — day 21, dose 2

2021-05-01

Symptoms: Missed period. Confirmed that I am not pregnant

Release 11 — 12 months, dose 2

2022-04-12

Symptoms: Leukocytoclastic vasculitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Amenorrhoea	✓	✓	✓
SD	Cutaneous vasculitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release